Abbott Laboratories (ABT) engages in the discovery, development, manufacture, and sale of a line of health care and pharmaceutical products. Below you will find selected information from Value Line. Use the Value Line estimated 2012 figures as the actual year-end figures for the company. The beta reported was .6 and the risk-free rate was 3.21 percent. Assume a market risk premium of 6 percent.

The high and low share price each year were:

		2008		2009		2010		2011		2012
High	$	78	$	57.9	$	60.3	$	64.3	$	57.4
Low		66.5		45.7		44.8		45.8		43.7

Using the P/E, P/CF, and P/S ratios, estimate the 2013 share price for Abbott Laboratories. Use the average stock price each year to calculate the price ratios. (Do not round intermediate calculations. Round your answers to 2 decimal places. Omit the "$" sign in your response.)

Price ratio
P/E	$
P/CF	$
P/S	$